Tag:

Aura BioSciences

Latest Headlines

Aura BioSciences banks $4.5M from private backers

September 8, 2011

Cambridge, MA-based Aura BioSciences says it has rounded up $4.5 million from unnamed investors to back its work on an innovative nanotech delivery system for cancer drugs. As Xconomy notes, Aura is

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Director, Pharmacovigilance and Drug Safety
TESARO - Waltham, MA
Senior Manager, Global Market Insights Job
Celgene Corporation - Summit, NJ, US
Director, Quality
Sucampo Pharmaceuticals - Washington, DC
Research & Development Chemist
C3 Jian - Marina Del Rey, CA
Statistician Job
Yoh - Montville, NJ, USA

Aura BioSciences

Latest Headlines

Latest Headlines